NUH and biotech firms Thermo Fisher Scientific and Mirxes signed a Memorandum of Understanding to collaborate on the development and clinical validation of next-generation sequencing (NGS) genomic testing solutions tailored for the Southeast Asian population. A/Prof Tan Soo Yong, Head & Senior Consultant, Department of Pathology, NUH highlighted the potential of such collaborative partnerships in improving early detection and delivering precise diagnoses and treatments for cancer.